Abstract
The lack of safe and effective antiepileptic drugs is a persistent issue that could be addressed through the repurposing or further development of commonly available drugs. Due to high accuracy, low effort, and high cost, it is best to begin the search for alternative treatments with a theoretical chemical study. Isoindoline derivatives, their ΔG, and their molecular docking were subjected to the molecular level theory. Having a ΔG of -4.9, compound A1 demonstrated a unique activity against protein 1OHV (4-aminobutyrate-aminotransferase; from pig), while the same compound demonstrated distinct activity against protein 3F8E (coumarins as suicide carbonic anhydrase inhibitors) with a ΔG of -4.533. Moreover, compound A3 exhibited a unique activity against protein 6KZP (calcium channel-ligand) with a ΔG of -7.597. The undertaken DFT analysis determined the highest occupied molecular orbital (HOMO), the least unoc¬cupied molecular orbital (LUMO), and the HOMO-LUMO gap values for the studied derivatives (compound A1: -0.202, -0.091, and -0.111 eV; compound A3: -0.228, -0.102, and -0.126 eV, respectively). The ionization potential, the soft¬ness, the hardness, and other chemical properties of these compounds were subsequently computed. Drug likeness predictions were employed in order to show that the compounds adhered to Lipinski’s rule. Our results indicate that the molecular mass, log P, as well as the hydrogen bonding donors and acceptors of the herein assessed isoindoline compounds fall within acceptable ranges.
Reference7 articles.
1. 1. Goldberg E.M., Coulter D.A.: Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction. Nat. Rev. Neurosci. 14(5): 337-349 (2013).
2. 2. National Clinical Guideline Centre (UK): The Epilepsies: The Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care: Pharmacological Update of Clinical Guideline 20. London: Royal College of Physicians (UK) (2012).
3. 3. Helmers S.L., Kobau R., Sajatovic M., Jobst B.C., Privitera M., Devinsky O., et al.: Self-management in epilepsy: why and how you should incorporate self-management in your practice. Epilepsy Behav. 68: 220-224 (2017).
4. 4. Meng X.Y., Zhang H.X., Mezei M., Cui M.: Molecular docking: a powerful approach for structure-based drug discovery. Curr. Comput. Aided Drug Des. 7(2): 146-157 (2011).
5. 5. Shi Y., Szlufarska I.: Wear-induced microstructural evolution of nanocrystalline aluminum and the role of zirconium dopants. Acta Mater. 200: 432-441 (2020).